Cholesterol-tuned liposomal membrane rigidity directs tumor penetration and anti-tumor effect
查看参考文献51篇
文摘
|
Recently, liposomes have been widely used in cancer therapeutics, but their anti-tumor effects are suboptimal due to limited tumor penetration. To solve this problem, researchers have made significant efforts to optimize liposomal diameters and potentials, but little attention has been paid to liposomal membrane rigidity. Herein, we sought to demonstrate the effects of cholesterol-tuned liposomal membrane rigidity on tumor penetration and anti-tumor effects. In this study, liposomes composed of hydrogenated soybean phospholipids (HSPC), 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000] (DSPE-PEG2000) and different concentrations of cholesterol were prepared. It was revealed that liposomal membrane rigidity decreased with the addition of cholesterol. Moderate cholesterol content conferred excellent diffusivity to liposomes in simulated diffusion medium, while excessive cholesterol limited the diffusion process. We concluded that the differences of the diffusion rates likely stemmed from the alterations in liposomal membrane rigidity, with moderate rigidity leading to improved diffusion. Next, the in vitro tumor penetration and the in vivo anti-tumor effects were analyzed. The results showed that liposomes with moderate rigidity gained excellent tumor penetration and enhanced anti-tumor effects. These findings illustrate a feasible and effective way to improve tumor penetration and therapeutic efficacy of liposomes by changing the cholesterol content, and highlight the importance of liposomal membrane rigidity. |
来源
|
Acta Pharmaceutica Sinica B
,2019,9(4):858-870 【核心库】
|
DOI
|
10.1016/j.apsb.2019.02.010
|
关键词
|
Cholesterol
;
Liposomal membrane rigidity
;
Tumor penetration
;
Anti-tumor effects
|
地址
|
1.
Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang, 117004
2.
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203
|
语种
|
英文 |
文献类型
|
研究性论文 |
ISSN
|
2211-3835 |
学科
|
药学 |
基金
|
国家自然科学基金
;
the Science and Technology Innovation Action Plan for Basic Research of Shanghai 2014
;
Shanghai Sailing Program 2017
|
文献收藏号
|
CSCD:6552418
|
参考文献 共
51
共3页
|
1.
Li H J. Smart superstructures with ultrahigh pH-sensitivity for targeting acidic tumor microenvironment: instantaneous size switching and improved tumor penetration.
ACS Nano,2016,10:6753-6761
|
CSCD被引
32
次
|
|
|
|
2.
Li H J. Stimuliresponsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.
Proc Natl Acad Sci U S A,2016,113:4164-4169
|
CSCD被引
49
次
|
|
|
|
3.
Sun Q H. Rational design of cancer nanomedicine: nanoproperty integration and synchronization.
Adv Mater,2017,29:1606628
|
CSCD被引
64
次
|
|
|
|
4.
Kaur S. Mucins in pancreatic cancer and its microenvironment.
Nat Rev Gastroenterol Hepatol,2013,10:607-620
|
CSCD被引
9
次
|
|
|
|
5.
Bhaw-Luximon A. New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: selective stroma depletion combined with nano drug delivery.
Cancer Lett,2015,369:266-273
|
CSCD被引
1
次
|
|
|
|
6.
Curry F R. Drug delivery: redefining tumour vascular barriers.
Nat Nanotechnol,2016,11:494-496
|
CSCD被引
1
次
|
|
|
|
7.
Levental K R. Matrix crosslinking forces tumor progression by enhancing integrin signaling.
Cell,2009,139:891-906
|
CSCD被引
77
次
|
|
|
|
8.
Daraee H. Application of liposomes in medicine and drug delivery.
Artif Cells Nanomed Biotechnol,2014,44:381-391
|
CSCD被引
10
次
|
|
|
|
9.
Zhang J. Co-delivery of doxorubicin and the traditional Chinese medicine quercetin using biotin-PEG2000-DSPE modified liposomes for the treatment of multidrug resistant breast cancer.
RSC Adv,2016,6:113173-84
|
CSCD被引
2
次
|
|
|
|
10.
Hong E J. Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials.
Acta Pharm Sin B,2016,6:297-307
|
CSCD被引
23
次
|
|
|
|
11.
Cabral H. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size.
Nat Nanotechnol,2011,6:815-823
|
CSCD被引
81
次
|
|
|
|
12.
Wang H X. Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines.
Nano Today,2016,11:133-144
|
CSCD被引
17
次
|
|
|
|
13.
Taha E I. Design of liposomal colloidal systems for ocular delivery of ciprofloxacin.
Saudi Pharm J,2014,22:231-239
|
CSCD被引
2
次
|
|
|
|
14.
Roy B. Influence of lipid composition, pH, and temperature on physicochemical properties of liposomes with curcumin as model drug.
J Oleo Sci,2016,65:399-411
|
CSCD被引
4
次
|
|
|
|
15.
Guo P. Nanoparticle elasticity directs tumor uptake.
Nat Commun,2018,9:130
|
CSCD被引
11
次
|
|
|
|
16.
Stern T. Rigidity of polymer micelles affects interactions with tumor cells.
J Control Release,2017,257:40-50
|
CSCD被引
2
次
|
|
|
|
17.
Nakano K. A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy.
Int J Pharm,2008,355:203-209
|
CSCD被引
5
次
|
|
|
|
18.
Spyratou E. Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems.
Expert Opin Drug Deliv,2009,6:305-317
|
CSCD被引
2
次
|
|
|
|
19.
Deng H. Modulating the rigidity of nanoparticles for tumor penetration.
Chem Commun,2018,54:3014-3017
|
CSCD被引
1
次
|
|
|
|
20.
Rog T. Ordering effects of cholesterol and its analogues.
Biochim Biophys Acta,2009,1788:97-121
|
CSCD被引
6
次
|
|
|
|
|